Astralean: Advanced Fat Loss and Performance Support
| Product dosage: 40mcg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.92 | $49.20 (0%) | 🛒 Add to cart |
| 20 | $3.31 | $98.40 $66.27 (33%) | 🛒 Add to cart |
| 30 | $2.81 | $147.59 $84.34 (43%) | 🛒 Add to cart |
| 60 | $2.29 | $295.19 $137.55 (53%) | 🛒 Add to cart |
| 90 | $2.12 | $442.78 $190.77 (57%) | 🛒 Add to cart |
| 120 | $2.03 | $590.37 $243.98 (59%) | 🛒 Add to cart |
| 180 | $1.95 | $885.56 $351.41 (60%) | 🛒 Add to cart |
| 270 | $1.96 | $1328.34 $529.13 (60%) | 🛒 Add to cart |
| 360 | $1.87
Best per pill | $1771.12 $672.70 (62%) | 🛒 Add to cart |
Astralean (clenbuterol hydrochloride) is a potent bronchodilator and thermogenic agent with established applications in respiratory medicine and body composition management. Originally developed for treating asthma and chronic obstructive pulmonary disease (COPD), its secondary thermogenic properties have made it a subject of significant clinical interest for metabolic enhancement. This beta-2 adrenergic agonist stimulates both the respiratory and central nervous systems, producing notable effects on oxygen transportation, metabolic rate, and energy utilization. Medical supervision is strongly advised due to its potent pharmacological profile and narrow therapeutic window. Proper dosing protocols and monitoring are essential for mitigating risks while maximizing potential benefits.
Features
- Active ingredient: Clenbuterol hydrochloride 20mcg or 40mcg tablets
- Pharmacological class: Selective beta-2 adrenergic receptor agonist
- Half-life: Approximately 28-36 hours
- Bioavailability: 70-80% oral administration
- Excretion: Primarily renal (urinary)
- Thermic effect: Increases basal metabolic rate by 10-15%
- Bronchodilatory effect: Lasts 6-8 hours per dose
Benefits
- Significant enhancement of respiratory function through bronchodilation
- Elevated metabolic rate leading to increased fat oxidation and weight management
- Improved oxygen transportation and aerobic capacity
- Enhanced athletic performance and endurance through optimized pulmonary function
- Appetite suppression through central nervous system stimulation
- Preservation of lean muscle mass during caloric deficit phases
Common use
Astralean is primarily prescribed for the management of asthma and chronic obstructive pulmonary disease where traditional bronchodilators prove insufficient. Its off-label applications include adjunct therapy for weight management in clinically supervised obesity treatment programs. In performance contexts, it may be used under medical supervision to enhance pulmonary function and metabolic efficiency. The medication is typically incorporated into comprehensive treatment plans that include dietary modification, exercise programming, and regular medical monitoring.
Dosage and direction
Initial dosing should begin at 20mcg once daily, preferably in the morning to minimize sleep disruption. Dosage may be gradually increased by 20mcg every 3-4 days based on tolerance and therapeutic response, not exceeding 120-140mcg daily for most individuals. Cycling protocols (2 weeks on/2 weeks off) are commonly implemented to prevent receptor downregulation. Administration with food may reduce gastrointestinal discomfort. Always follow precise medical guidance regarding dosage titration and duration of use.
Precautions
Regular monitoring of heart rate, blood pressure, and electrolyte levels is essential throughout treatment. Hydration should be maintained at increased levels (2-3 liters daily) to support cardiovascular function. Potassium and taurine supplementation may be necessary to counteract potential electrolyte depletion. Avoid concomitant use of other stimulants including caffeine, ephedrine, or other sympathomimetic agents. Discontinuation should be gradual rather than abrupt to prevent rebound effects.
Contraindications
Astralean is contraindicated in patients with:
- Cardiovascular disease including hypertension, arrhythmias, or coronary artery disease
- Hyperthyroidism or thyrotoxicosis
- History of myocardial infarction or stroke
- Severe hepatic or renal impairment
- Pregnancy and lactation
- Known hypersensitivity to clenbuterol or related compounds
- Concurrent MAOI antidepressant therapy
Possible side effects
Common side effects (dose-dependent) include:
- Tachycardia and palpitations
- Tremors, nervousness, and anxiety
- Insomnia and sleep disturbances
- Increased sweating and body temperature
- Muscle cramps (particularly in calf muscles)
- Headaches and dizziness
- Nausea and gastrointestinal discomfort
Less common but serious side effects requiring immediate medical attention:
- Chest pain or irregular heartbeat
- Severe hypotension or hypertension
- Electrolyte imbalance symptoms
- Allergic reactions including rash or breathing difficulties
Drug interactions
Significant interactions occur with:
- Other beta-agonists (additive cardiovascular effects)
- MAO inhibitors and tricyclic antidepressants (hypertensive crisis risk)
- Diuretics (increased electrolyte depletion)
- Thyroid medications (potentiated thermogenic effects)
- Stimulants including caffeine, ephedrine (increased side effect profile)
- QT-prolonging medications (increased arrhythmia risk)
- Digoxin (potential for increased cardiotoxicity)
Missed dose
If a dose is missed, take it as soon as remembered unless it is nearly time for the next scheduled dose. Do not double the dose to make up for a missed administration. Maintain regular dosing schedule without compensation for missed doses. Consistency in dosing helps maintain stable plasma concentrations and reduces side effect fluctuations.
Overdose
Overdose symptoms include severe tachycardia (heart rate exceeding 120 bpm), hypertension, tremors, anxiety, cardiac arrhythmias, hypokalemia, and hyperglycemia. In case of suspected overdose, seek immediate medical attention. Treatment is supportive and may include beta-blockers (cardioselective preferred), electrolyte replacement, and continuous cardiac monitoring. Gastric lavage may be considered if ingestion occurred within previous hour.
Storage
Store at room temperature (15-30°C/59-86°F) in original packaging protected from light and moisture. Keep tightly closed and out of reach of children. Do not use after expiration date printed on packaging. Avoid storage in bathrooms or other humid environments. Proper disposal of unused medication should follow local regulations for pharmaceutical waste.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Astralean is a prescription medication that should only be used under direct medical supervision. Individual responses may vary based on health status, genetics, and concomitant medications. Always consult with a qualified healthcare professional before beginning any new medication regimen. The off-label uses described may not be approved in all jurisdictions.
Reviews
Clinical studies demonstrate Astralean’s efficacy in bronchial dilation and metabolic enhancement when properly administered. Patients report improved breathing capacity within days of initiation. Weight management applications show variable results depending on individual metabolic factors and adherence to comprehensive lifestyle modifications. Performance athletes note enhanced endurance metrics but frequently report side effects requiring careful dose management. Medical professionals emphasize the necessity of supervised use due to significant cardiovascular considerations.